Skip to main content
Premium Trial:

Request an Annual Quote

Illumina, Mount Sinai Services to Offer Verifi NIPT in Ontario

NEW YORK (GenomeWeb) – Mount Sinai Services today announced a distribution deal with Illumina to offer the Verifi non-invasive prenatal test in Ontario.

Mount Sinai Services said that the deal also provides it flexibility to offer the test in other regions in Canada. Financial and other terms of the deal were not disclosed. Illumina acquired the Verifi test when it purchased Verinata Health in 2013.

Verifi detects trisomies 21, 18, and 13, as well as sex chromosomes for monosomy X, Triple X syndrome, Klinefelter syndrome, and Jacobs syndrome. Additionally, the test helps to stratify the risk for certain X-linked disorders, such as hemophilia, Duchenne muscular dystrophy, or cases of ambiguous genitalia.

Mount Sinai Services is based in Toronto and provides customized laboratory and research services and works with Mount Sinai Hospital's laboratories, clinicians, and researchers.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.